MetaADEDB 2.0 @ LMMD
Product used for unknown indication
(UMLS:C2938933)
UMLS ID:
C2938933
MeSH ID:
N/A
Synonym(s)
1.
Product used for unknown indication
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1BMS201038FAERS: 97
Canada Vigilance: 2		Canada Vigilance
US FAERS
2TacrolimusFAERS: 19US FAERS
3AripiprazoleFAERS: 10US FAERS
4Ethylene GlycolFAERS: 5US FAERS
5CetirizineFAERS: 4US FAERS
6GabapentinFAERS: 4US FAERS
7AlbuterolFAERS: 3US FAERS
8AlbuterolFAERS: 3US FAERS
9Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
10tasimelteonFAERS: 3US FAERS
11AmoxicillinFAERS: 2
Canada Vigilance: 2		Canada Vigilance
US FAERS
12MiconazoleFAERS: 2US FAERS
13Nexium 24hrFAERS: 2US FAERS
14NuvaRingFAERS: 2US FAERS
15PCI 32765FAERS: 2US FAERS
16RisperidoneFAERS: 2US FAERS
17RivaroxabanFAERS: 2US FAERS
18TicagrelorFAERS: 2US FAERS
19apixabanFAERS: 2US FAERS
20olaparibFAERS: 2US FAERS
212-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chlorideFAERS: 1US FAERS
224-AminopyridineFAERS: 1US FAERS
234-[(1R)-2-[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanolFAERS: 1US FAERS
24AcetaminophenFAERS: 1US FAERS
25AcyclovirFAERS: 1US FAERS
26AlendronateFAERS: 1US FAERS
27Aleve PMFAERS: 1US FAERS
28AzathioprineFAERS: 1US FAERS
29Bevespi AerosphereFAERS: 1US FAERS
30BisoprololFAERS: 1US FAERS
31Breo ElliptaFAERS: 1US FAERS
32BudesonideFAERS: 1US FAERS
33BuprenorphineFAERS: 1US FAERS
34CitalopramFAERS: 1US FAERS
35DasatinibFAERS: 1US FAERS
36DiclofenacFAERS: 1US FAERS
37Duloxetine HydrochlorideFAERS: 1US FAERS
38FentanylFAERS: 1US FAERS
39FentanylFAERS: 1US FAERS
40HaloperidolFAERS: 1US FAERS
41Imodium Multi-Symptom ReliefFAERS: 1US FAERS
42LevofloxacinFAERS: 1US FAERS
43LinezolidFAERS: 1US FAERS
44LiraglutideFAERS: 1US FAERS
45LoratadineFAERS: 1US FAERS
46LorazepamFAERS: 1US FAERS
47MinocyclineFAERS: 1US FAERS
48MinoxidilFAERS: 1US FAERS
49NaproxenFAERS: 1US FAERS
50NitroxylFAERS: 1US FAERS
51OctreotideFAERS: 1US FAERS
52OmeprazoleFAERS: 1US FAERS
53PrednisoloneFAERS: 1US FAERS
54PrednisoneFAERS: 1US FAERS
55PregabalinFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
56Pyridostigmine BromideFAERS: 1US FAERS
57Quetiapine FumarateFAERS: 1US FAERS
58Sodium picosulfateFAERS: 1US FAERS
59SunitinibFAERS: 1US FAERS
60TamsulosinFAERS: 1US FAERS
61TapentadolFAERS: 1US FAERS
62ThyroxineFAERS: 1US FAERS
63TrazodoneFAERS: 1US FAERS
64Zegerid OTCFAERS: 1US FAERS
65abacavirFAERS: 1US FAERS
66bosutinibFAERS: 1US FAERS
67ceftolozane, tazobactam drug combinationFAERS: 1US FAERS
68dabrafenibFAERS: 1US FAERS
69etonogestrelFAERS: 1US FAERS
70ezogabineFAERS: 1US FAERS
71fexofenadineFAERS: 1US FAERS
72indacaterolFAERS: 1US FAERS
73palbociclibFAERS: 1US FAERS
74pimavanserinFAERS: 1US FAERS
75selexipagFAERS: 1US FAERS
76Atomoxetine HydrochlorideCanada Vigilance: 1Canada Vigilance
77AtorvastatinCanada Vigilance: 1Canada Vigilance
78CitalopramCanada Vigilance: 1Canada Vigilance
79EsomeprazoleCanada Vigilance: 1Canada Vigilance
80TemazepamCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.